Plain-English translation of NCT07377682 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is an observational study — meaning researchers watch and collect information from regular doctor visits rather than conducting a formal experiment. The study focuses on how trazodone hydrochloride (prolonged release) works in real-world clinical practice for people aged 55 and older who have major depression and mild cognitive impairment (early memory problems). Researchers will gather information from three countries — Italy, Poland, and Romania — to understand how well this medication helps patients with this combination of conditions.
Many older adults experience both depression and early memory loss at the same time, but there is limited real-world evidence about how well this medication works specifically for this group of patients. This study aims to fill that gap by collecting practical information from everyday clinical care.
You likely qualify if…
You likely don't qualify if…
You would continue taking the medication as your doctor prescribes it in normal clinical care. Researchers will collect information from your regular doctor visits and medical records over time to track how you respond to the treatment — such as changes in your mood and cognitive symptoms. There are no additional procedures or hospital visits required; you simply continue your normal care while sharing your health data with the research team.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Poland
Sponsor
Aziende Chimiche Riunite Angelini Francesco S.p.A
Collaborators
IQVIA Pty Ltd
Enrollment target
~120 participants
Started
December 2025
Primary completion
July 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
55 Years and older
Last updated on clinicaltrials.gov in January 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Alessandro Ruggieri
CAMPUS BioMedico
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.